Molecular Partners to Present at HC Wainwright and Morgan Stanley Healthcare Conferences
Back to Newsroom
Mentioned in this Article

Molecular Partners to Present at HC Wainwright and Morgan Stanley Healthcare Conferences

Friday, September 11, 2020 1:00 AM
Share this article now
Topic:
Conferences

ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / September 11, 2020 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new class of custom-built proteins known as DARPin® therapeutics, today announced that Patrick Amstutz, chief executive officer, will be presenting at the HC Wainwright 22nd Annual Global Investments Conference taking place September 14-16, 2020, as well as participating in a fireside chat at the Morgan Stanley Global Healthcare Conference taking place September 14-18, 2020.

Details for the presentations are as follows:

HC Wainwright 22nd Annual Global Investments Conference
Presentation Date: Monday, September 14, 2020
Presentation Time: 11:30 a.m. ET

Morgan Stanley Global Healthcare Conference
Presentation Date: Wednesday, September 16, 2020
Presentation Time: 1:15 p.m. ET

A webcast of the presentations will be available on the Molecular Partners website.

About Molecular Partners AG
Molecular Partners AG is a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin® therapeutics, designed to address challenges current modalities cannot. The company has compounds in various stages of clinical and preclinical development with a focus on oncology. Molecular Partners has formed partnerships with leading pharmaceutical companies to advance DARPin® therapeutics across multiple therapeutic areas.

For further details, please contact:
Seth Lewis, SVP IR, Comms, & Strategy
[email protected]
Tel: +1 781 420 2361

Tom Donovan, U.S. Media
[email protected]
Tel: +1 857 559 3397

Thomas Schneckenburger, IR & European Media
[email protected]
Tel: +41 79 407 9952

SOURCE: Molecular Partners AG

Molecular Partners AG
Back to Newsroom
Copyright 2020 © ACCESSWIRE. All rights reserved. Privacy Policy  |  Terms and Conditions
Drop us a line: